Universe Pharmaceuticals, Inc. is a pharmaceutical company. The company is headquartered in Ji'An, Jiangxi and currently employs 225 full-time employees. The company went IPO on 2021-03-23. Through its subsidiary, the Company sells TCMD products, biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies. Its TCMD products fall into two categories: chronic condition treatments as well as cold and flu medications, including Guben Yanling Pill, Shenrong Weisheng Pill, Fengshitong Medicinal Liquor, Isatis Root Granule and Qiangli Pipa Syrup. Its major customers are pharmaceutical companies, hospitals, clinics and drugstore chains. The firm mainly conducts its businesses within the Chinese market.
UPC stock price ended at $4.51 on 金曜日, after dropping 1.74%
On the latest trading day Jan 16, 2026, the stock price of UPC fell by 1.74%, dropping from $4.43 to $4.51. During the session, the stock saw a volatility of 5.57%, with prices oscillating between a daily low of $4.31 and a high of $4.55. On the latest trading day, the trading volume for UPC decreased by 20.9K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 13.9K shares were traded, with a market value of approximately $2.5M.